Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Good
|
|
New words:
Britain, cardiac, decade, discrete, Eurodollar, European, exit, Great, heart, heavy, Insight, large, liquid, low, mature, Medtech, modest, priority, raw, resolution, sector, strategy, therapeutic, type, typically, Union, variety
Removed:
adulterated, alleged, Antonio, assessment, Australia, Canada, category, commerce, conspired, debt, declining, determine, Europe, facility, functional, guaranteed, imaging, indictment, interstate, introduced, Japan, misbranded, Moody, nationally, Poor, promotion, rated, San, screen, shareholder
Filing tables
Filing exhibits
Related press release
Vascular Solutions similar filings
Filing view
External links
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Vascular Solutions, Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2016, as filed with the Securities and Exchange Commission (the “Report”), I, James Hennen, Chief Financial Officer of the Company, certify to my knowledge, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ James Hennen | |
| James Hennen | |
| Senior Vice President of Finance and | |
| Chief Financial Officer | |
| July 25, 2016 |